Clinical Study
Flow-Mediated Vasodilation Is Not Attenuated in Hypertensive Pregnancies Despite Biochemical Signs of Inflammation
Table 3
Concentrations of hsCRP, IL-6, and TNF-α during pregnancy and postpartum. Medians (minimum-maximum).
| | | Pregnancy | Postpartum | |
| hsCRP (mg/L) | Control | 3.0 (0.54–13.4) | 2.4 (0.22–7.0) | 0.212 | Hypertensive | 4.5 (0.89–38) | 0.80 (0.27–5.9) | 0.023* | | 0.328 | 0.879 | |
| IL-6 (pg/mL) | Control | 1.8 (0.64–5.4) | 1.3 (0.31–5.1) | 0.118 | Hypertensive | 2.1 (0.70–11) | 1.2 (0.73–3.0) | 0.006* | | 0.137 | 0.879 | |
| TNF-α (pg/mL) | Control | 2.0 (1.2–4.1) | 1.8 (1.1–4.0) | 0.451 | Hypertensive | 1.9 (0.88–3.2) | 1.5 (0.71–2.1) | 0.030* | | 0.595 | 0.101 | |
|
|
*: value .
|